Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer.
Ontology highlight
ABSTRACT: Our results show that everolimus delays mammary tumor formation in multiple mouse models, suggesting that mTOR inhibitors will be useful for the prevention of ER-negative and triple-negative breast cancer in humans. See related Spotlight, p. 787.
SUBMITTER: Mazumdar A
PROVIDER: S-EPMC9762336 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA